As a premier global destination for high-value scientific activity, Hyderabad’s life sciences ecosystem has evolved into a powerhouse for global health, accounting for one-third of the world’s vaccine production. Known as the "Vaccine Capital of the World," the city is anchored by Genome Valley, India’s first organized R&D cluster, which houses over 200 companies including global giants like Novartis, GSK and Sanofi.
Hyderabad is a leader in pharmaceutical manufacturing, contributing 40% of India’s total drug production through industry titans like Dr. Reddy’s Laboratories and Aurobindo Pharma. The city’s biotechnology sector is at the frontier of innovation, focusing on cell and gene therapy, biosimilars and mRNA platforms under the strategic Next-Gen Life Sciences Policy 2026–30.
Furthermore, the Telangana Medical Devices Park in Sultanpur stands as India’s largest functional cluster for medtech, fostering the development of advanced diagnostic kits and surgical implants.
The ecosystem is enriched by healthcare innovation hubs and Global Capability Centres (GCCs) from leaders like Medtronic and Bristol Myers Squibb, which leverage the city’s robust STEM talent pool.
Academic research is propelled by prestigious institutions such as CCMB and IIT Hyderabad, ensuring a steady pipeline of translational research and skilled professionals.
With the upcoming Hyderabad Pharma City, the region is set to become the world's largest integrated pharmaceutical industrial park, emphasizing sustainable "Green Pharma" practices.
This integrated approach, spanning discovery, development and deployment, positions Hyderabad among the top five global life sciences clusters, offering an unparalleled environment for biopharma investment and cross-border collaboration.
